The week in health tech, explained in plain English.Get the free newsletter →
November 1, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Why Health Plans Keep Losing on Out-of-Network Claims

Out-of-network claims are quietly draining health plans, and the arbitration process meant to settle them is tilted against payers. According to Healthcare Dive, roughly 88% of disputes that reach the federal Independent Dispute Resolution (IDR) process under the No Surprises Act are decided in favor of providers. When a claim lands in IDR, the plan usually loses and ends up paying more than it expected.

The volume of IDR cases has far exceeded what regulators anticipated when the No Surprises Act took effect, straining a system that was supposed to be a last resort. Every dispute also carries administrative cost and arbitration fees on top of the eventual payout, so escalation is expensive even before the ruling.

The practical takeaway for payers is to solve OON claims earlier. Accurate pricing, faster resolution, and better initial payment determinations keep claims out of arbitration entirely. Plans that treat IDR as the fix are optimizing the wrong end of the process.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.